Evidence map›Paper›PMID 35565475›Full record

ArticleCancers2022

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.

Hélène Bonsang-Kitzis, Nabilah Panchbhaya, Anne-Sophie Bats, Eric Pujade-Lauraine, Patricia Pautier, Charlotte Ngô, Marie-Aude Le Frère-Belda, Elsa Kalbacher, Anne Floquet, Dominique Berton-Rigaud and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

Hélène Bonsang-KitzisGynecological and Breast Surgery and Cancerology Center, RAMSAY-Générale de Santé, Hôpital Privé des Peupliers, 75013 Paris, France.
Nabilah PanchbhayaDepartment of Obsterics and Gynecology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 75020 Paris, France.
Anne-Sophie BatsDepartment of Breast and Gynecological Surgical Oncology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, 75015 Paris, France.
Eric Pujade-LauraineGINECO/TMRG Network, 75008 Paris, France.
Patricia PautierGINECO/TMRG Network, 75008 Paris, France.
Charlotte NgôGynecological and Breast Surgery and Cancerology Center, RAMSAY-Générale de Santé, Hôpital Privé des Peupliers, 75013 Paris, France.
Marie-Aude Le Frère-BeldaGINECO/TMRG Network, 75008 Paris, France.ORCID 0000-0001-8558-4524
Elsa KalbacherGINECO/TMRG Network, 75008 Paris, France.
Anne FloquetGINECO/TMRG Network, 75008 Paris, France.
Dominique Berton-RigaudGINECO/TMRG Network, 75008 Paris, France.
Claudia Lefeuvre-PlesseGINECO/TMRG Network, 75008 Paris, France.
Michel FabbroGINECO/TMRG Network, 75008 Paris, France.
Isabelle Ray-CoquardGINECO/TMRG Network, 75008 Paris, France.ORCID 0000-0003-2472-8306
Fabrice LécuruGINECO/TMRG Network, 75008 Paris, France.
Assistance Publique – Hôpitaux de Paris · FRGénérale de Santé · FRUniversité Paris Cité · FRCentre Eugène Marquis · FRHôpital Privé Jean Mermo · FRInstitut Bergonié · FRInstitut de Cancérologie de l'Ouest · FRInstitut de Recherche en Cancérologie de Montpellier · FRInstitut Gustave Roussy · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The surgical specificities of advanced low-grade serous ovarian carcinoma (LGSOC) have been little investigated. Our objective was to describe surgical procedures/complications in primary (PDS) compared to interval debulking surgery (neoadjuvant chemotherapy and interval debulking surgery, NACT-IDS) and to assess the survival (progression-free (PFS) and overall survival (OS)) in patients with advanced LGSOC. We retrospectively analyzed advanced LGSOC from a nationwide registry (January 2000 to July 2017). A total of 127 patients were included (48% PDS and 35% NACT-IDS). Peritoneal carcinomatosis was more severe (

Indexed as

advanced stagelow-grade serous ovarian cancerneoadjuvant chemotherapysurgerysurvival

Identifiers

PMID35565475
PMCPMC9105599
OpenAlexW4229444826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.